Claims for Patent: 11,406,662

Summary for Patent: 11,406,662

Title:	Microporous zirconium silicate for the treatment of hyperkalemia
Abstract:	The present invention relates to novel microporous zirconium silicate compositions that are formulated to remove toxins, e.g. potassium ions, from the gastrointestinal tract at an elevated rate without causing undesirable side effects. The preferred formulations are designed avoid increase in pH of urine in patients and/or avoid potential entry of particles into the bloodstream of the patient. Also disclosed is a method for preparing high purity crystals of UZSi-9 exhibiting an enhanced level of potassium exchange capacity. These compositions are particularly useful in the therapeutic treatment of hyperkalemia.
Inventor(s):	Donald Jeffrey Keyser, Alvaro F. GUILLEM
Assignee:	ZS Pharma Inc
Application Number:	US16/850,468
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 11,406,662
Patent Claims:	1. A cation exchange composition consisting of zirconium silicate wherein the composition exhibits an x-ray powder diffraction spectrum generated using a copper K-alpha radiation source indicating at least the following values: a first peak at 2 theta corresponding to a first d-spacing within the range of 2.7-3.5 angstroms having a first intensity value, a second peak at 2 theta corresponding to a second d-spacing within the range of 5.3-6.1 having a second intensity value, wherein the second intensity value is less than the first intensity value, a third peak at 2 theta corresponding to a third d-spacing within the range of 1.6-2.4 angstroms having a third intensity value, a fourth peak at 2 theta corresponding to a fourth d-spacing within the range of 2.0-2.8 angstroms having a fourth intensity value, and a fifth peak at 2 theta corresponding to a fifth d-spacing within the range of 5.9-6.7 angstroms having a fifth intensity value, wherein the third, fourth, and fifth intensity values are each lower than the first and second intensity values, wherein the composition exhibits a median particle size of greater than 3 microns, and the composition exhibits a sodium content below 12% by weight. 2. The composition of claim 1, wherein less than 7% of the particles in the composition have a diameter less than 3 microns. 3. The composition of claim 1, wherein less than 4% of the particles in the composition have a diameter less than 3 microns. 4. The composition of claim 1, wherein less than 1% of the particles in the composition have a diameter less than 3 microns. 5. The composition of claim 1, wherein the median particle size ranges from 5 to 1000 microns. 6. The composition of claim 1, wherein the median particle size ranges from 20 to 100 microns. 7. The composition of claim 1, wherein the zirconium silicate is of formula (I): ApMxZr1-xSinGeyOm (I) where A is a potassium ion, sodium ion, rubidium ion, cesium ion, calcium ion, magnesium ion, hydronium ion or mixtures thereof, M is at least one framework metal, wherein the framework metal is hafnium (4+), tin (4+), niobium (5+), titanium (4+), cerium (4+), germanium (4+), praseodymium (4+), terbium (4+) or mixtures thereof, “p” has a value from about 1 to about 20, “x” has a value from 0 to less than 1, “n” has a value from about 0 to about 12, “y” has a value from 0 to about 12, “m” has a value from about 3 to about 36 and 1≤n+y≤12.